US FDA approves label update for Kite's (GILD) Yescarta for relapsed or refractory PCNSL
Importance
Level 1
#GILEAD SCIENCES INC#GILD.US#FDA#EQUITIES#EU SESSION#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#GILD#US EQUITIES